What is a stock summary page? Click here for an overview.
Business Description
AlloVir Inc
NAICS : 541714
SIC : 2834
ISIN : US0198181036
Share Class Description:
ALVR: Ordinary SharesDescription
AlloVir Inc is a biopharmaceutical company. The company focuses on developing allogeneic T-cell therapies to combat viral diseases. Their proprietary virus-specific T cell VST therapy platform enables the creation of off-the-shelf VSTs, therapy platform allows AlloVir to generate off-the-shelf VSTs designed to restore immunity in patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases. This included: (1) posoleucel (ALVR105), an investigational off-the-shelf multi-virus-specific T cell therapy. (2) ALVR106, an allogeneic, off-the-shelf VST therapy candidate developed to target devastating diseases caused by four respiratory viruses. (3) ALVR107, an allogeneic, off-the-shelf VST therapy candidate designed to target hepatitis B (HBV).
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 13.14 | |||||
| Equity-to-Asset | 0.96 | |||||
| Debt-to-Equity | 0.08 | |||||
| Debt-to-EBITDA | -0.16 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 43.8 | |||||
| 3-Year EPS without NRI Growth Rate | 46.4 | |||||
| 3-Year FCF Growth Rate | 29.7 | |||||
| 3-Year Book Growth Rate | -34.9 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58.54 | |||||
| 9-Day RSI | 53.2 | |||||
| 14-Day RSI | 50.87 | |||||
| 3-1 Month Momentum % | -7.54 | |||||
| 6-1 Month Momentum % | -45.25 | |||||
| 12-1 Month Momentum % | -43.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 22.63 | |||||
| Quick Ratio | 22.63 | |||||
| Cash Ratio | 22.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -22.2 | |||||
| Shareholder Yield % | 35.85 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -47.32 | |||||
| ROA % | -41.56 | |||||
| ROIC % | -873.01 | |||||
| 3-Year ROIIC % | -264.64 | |||||
| ROC (Joel Greenblatt) % | -717.52 | |||||
| ROCE % | -41.74 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.44 | |||||
| Price-to-Tangible-Book | 0.44 | |||||
| EV-to-EBIT | 1.25 | |||||
| EV-to-EBITDA | 1.25 | |||||
| EV-to-FCF | 1.02 | |||||
| Price-to-Net-Current-Asset-Value | 0.44 | |||||
| Price-to-Net-Cash | 0.44 | |||||
| Earnings Yield (Greenblatt) % | 80 | |||||
| FCF Yield % | -136.85 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ALVR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AlloVir Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -11.73 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.82 | ||
| 3-Year Sortino Ratio | -0.97 | ||
| Volatility % | 52.06 | ||
| 14-Day RSI | 50.87 | ||
| 14-Day ATR ($) | 0.608767 | ||
| 20-Day SMA ($) | 9.73505 | ||
| 12-1 Month Momentum % | -43.15 | ||
| 52-Week Range ($) | 7.96 - 24.149999 | ||
| Shares Outstanding (Mil) | 5.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AlloVir Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
AlloVir Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
AlloVir Inc Frequently Asked Questions
What is AlloVir Inc(ALVR)'s stock price today?
The current price of ALVR is $9.81. The 52 week high of ALVR is $24.15 and 52 week low is $7.96.
When is next earnings date of AlloVir Inc(ALVR)?
The next earnings date of AlloVir Inc(ALVR) is 2025-05-13 Est..
Does AlloVir Inc(ALVR) pay dividends? If so, how much?
AlloVir Inc(ALVR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers